FDA Recall Terminated Historical recordClass II
Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cincinnati OH 45237 USA, NDC 0591-0900-30, UPC 3-0591090030-4
- Reason
- Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point.
- Published
- February 22, 2017
- Distribution
- Nationwide
